Clinical efficacy analysis of acupuncture combined with anti-tumor necrosis factor treatment for spleen and kidney yang deficiency type ulcerative colitis - Top-Institutions - MDSpire

Clinical efficacy analysis of acupuncture combined with anti-tumor necrosis factor treatment for spleen and kidney yang deficiency type ulcerative colitis

  • By

  • Pengfei Qin

  • Yunchun Luo

  • Yuzhou Yao

  • Ni Zhu

  • Wen Yi

  • July 1, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Guang’anmen Hospital, China Academy of Chinese Medical Sciences
    Guang’anmen Hospital, China Academy of Chinese Medical Sciences

    Beijing, China

    Key Differentiators

    • Acupuncture
    • Gastroenterology

  • #2

    Shanghai University of Traditional Chinese Medicine
    Shanghai University of Traditional Chinese Medicine

    Shanghai, China

    Key Differentiators

    • Acupuncture
    • Gastroenterology

  • #3

    University of California San Diego
    University of California San Diego

    La Jolla, California

    Key Differentiators

    • Gastroenterology

  • #4

    Catholic University of Korea
    Catholic University of Korea

    Seoul, South Korea

    Key Differentiators

    • Gastroenterology

  • #5

    Far Eastern Memorial Hospital
    Far Eastern Memorial Hospital

    New Taipei City, Taiwan

    Key Differentiators

    • Gastroenterology

Original Source(s)

Clinical efficacy analysis of acupuncture combined with anti-tumor necrosis factor treatment for spleen and kidney yang deficiency type ulcerative colitis

  • by Pengfei Qin, Yunchun Luo, Yuzhou Yao, Ni Zhu, Wen Yi

  • July 1, 2026

Related Content

Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer

Single-center experience of interventional therapy for congenital portal-systemic shunt in children

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review